Clinical trials
Urinary Incontinence trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 5 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 5 |
| Astellas Pharma Europe B.V. | 4 |
| Astellas Pharma Inc | 4 |
| Astellas Pharma Europe Ltd. | 2 |
| Essity Hygiene and Health AB | 2 |
| APOGEPHA Arzneimittel GmbH | 1 |
| Bayer | 1 |
| Coloplast A/S | 1 |
| Contura | 1 |
| Dr. August Wolff GmbH & Co. KG Arzneimittel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Incontinence | 34 |
| Urinary Bladder, Overactive | 19 |
| Urologic Diseases | 5 |
| Urinary Incontinence, Urge | 4 |
| Prostatic Neoplasms | 3 |
| Urinary Bladder Diseases | 3 |
| Nocturia | 2 |
| Pelvic Organ Prolapse | 2 |
| Urinary Incontinence, Stress | 2 |
| Cystocele | 1 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.